Back to search
FDAFDA · Food and drugs·Recall number Z-1465-2013

Active Articulation E1. Intended for use with either primary or revision hip arthroplasty.

Published June 12, 2013 · Recall initiated: April 26, 2013

Summary

FDA records medical device Class II recall Z-1465-2013, published June 12, 2013 and initiated April 26, 2013. Recalling firm: Biomet, Inc.; Status: Terminated; Reported quantity: 8 units; Lot: Part numbers: EP-200162, EP-200162, EP-200164, and EP-200166 with Lot numbers: 027050, 101470, 115950, 101480, 247990, 948810, 967270, 027070, 287820, 729870, and 860880. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Biomet is recalling Active Articulation E1 Hip Bearing implants. Biomet has initiated this action following an investigation which identified that outer label indicates two conflicting O.D. sizes while the inner labels indicate an incorrect O.D. size. The implant itself is etched with the correct O.D. size.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomet, Inc.
Distributor
Distributed in New York.
Lot
Part numbers: EP-200162, EP-200162, EP-200164, and EP-200166 with Lot numbers: 027050, 101470, 115950, 101480, 247990, 948810, 967270, 027070, 287820, 729870, and 860880.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Active Articulation E1. Intended for use with either primary or revision hip arthroplasty. recalled?

Yes. FDA published recall Z-1465-2013 on June 12, 2013. Reported hazard: Biomet is recalling Active Articulation E1 Hip Bearing implants. Biomet has initiated this action following an investigation which identified that outer label indicates two conflicting O.D. sizes while the inner labels indicate an incorrect O.D. size. The implant itself is etched with the correct O.D. size.

What should I do if I have this product?

Voluntary: Firm initiated · Letter